345 related articles for article (PubMed ID: 25475205)
1. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of leishmaniasis. Part XI: synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivatives.
Suryawanshi SN; Tiwari A; Chandra N; Ramesh ; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6559-62. PubMed ID: 23031597
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
7. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Escobar P; Yardley V; Croft SL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of indolyl glyoxylamides as a new class of antileishmanial agents.
Chauhan SS; Gupta L; Mittal M; Vishwakarma P; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2010 Nov; 20(21):6191-4. PubMed ID: 20850302
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
10. Identification of the benzodiazepines as a new class of antileishmanial agent.
Clark RL; Carter KC; Mullen AB; Coxon GD; Owusu-Dapaah G; McFarlane E; Duong Thi MD; Grant MH; Tettey JN; Mackay SP
Bioorg Med Chem Lett; 2007 Feb; 17(3):624-7. PubMed ID: 17113290
[TBL] [Abstract][Full Text] [Related]
11. Novel Agents against Miltefosine-Unresponsive Leishmania donovani.
Das M; Saha G; Saikia AK; Dubey VK
Antimicrob Agents Chemother; 2015 Dec; 59(12):7826-9. PubMed ID: 26392497
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents.
Pandey S; Suryawanshi SN; Gupta S; Srivastava VM
Eur J Med Chem; 2005 Aug; 40(8):751-6. PubMed ID: 15907348
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of chalcones as potential antileishmanial agents.
Gupta S; Shivahare R; Korthikunta V; Singh R; Gupta S; Tadigoppula N
Eur J Med Chem; 2014 Jun; 81():359-66. PubMed ID: 24858541
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
15. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.
Dube A; Singh N; Sundar S; Singh N
Parasitol Res; 2005 Jun; 96(4):216-23. PubMed ID: 15868188
[TBL] [Abstract][Full Text] [Related]
16. Experimental chemotherapy with Allium sativum (Liliaceae) methanolic extract in rodents infected with Leishmania major and Leishmania donovani.
Wabwoba BW; Anjili CO; Ngeiywa MM; Ngure PK; Kigondu EM; Ingonga J; Makwali J
J Vector Borne Dis; 2010 Sep; 47(3):160-7. PubMed ID: 20834086
[TBL] [Abstract][Full Text] [Related]
17. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
[TBL] [Abstract][Full Text] [Related]
19. Identification of a diverse indole-2-carboxamides as a potent antileishmanial chemotypes.
Pandey S; Chauhan SS; Shivahare R; Sharma A; Jaiswal S; Gupta S; Lal J; Chauhan PM
Eur J Med Chem; 2016 Mar; 110():237-45. PubMed ID: 26840364
[TBL] [Abstract][Full Text] [Related]
20. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
